Gene expression signature of atypical breast hyperplasia and regulation by SFRP1

BACKGROUND: Atypical breast hyperplasias (AH) have a 10-year risk of progression to invasive cancer estimated at 4–7%, with the overall risk of developing breast cancer increased by ~ 4-fold. AH lesions are estrogen receptor alpha positive (ERα+) and represent risk indicators and/or precursor lesion...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Breast Cancer Res
Hauptverfasser: Gregory, Kelly J., Roberts, Amy L., Conlon, Erin M., Mayfield, Jacob A., Hagen, Mary J., Crisi, Giovanna M., Bentley, Brooke A., Kane, Jeffrey J., Makari-Judson, Grace, Mason, Holly S., Yu, Jun, Zhu, Lihua Julie, Simin, Karl, Johnson, Jacob P. S., Khan, Ashraf, Schneider, Ben R., Schneider, Sallie S., Jerry, D. Joseph
Format: Artigo
Sprache:Inglês
Veröffentlicht: BioMed Central 2019
Schlagworte:
Research Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6598287/
https://ncbi.nlm.nih.gov/pubmed/31248446
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13058-019-1157-5
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge